Digital Contract

What is the reason for changing to current treatment of OAB? (Please tick the appropriate options below.) *

Good efficacy Good tolerability Low efficacy of ongoing treatment Poor tolerability of ongoing treatment Any Other

Physician’s Assessment at End of Treatment

Poor Fair Good Very good Excellent

Physician tolerability assessment *

Poor Fair Good Very good Excellent

In what percentage of OAB patient do you prescribe following treatment? (Please enter values that total 100%)*

Patients Mirabegron 25 mg	%
Patients Mirabegron 50 mg	%
Patients Mirabegron 25 mg + Solifenacin 5 mg	%
Patients Mirabegron 50 mg + Solifenacin 5 mg	%
Patients Any Other	%

In what percentage of following challenging patient profile you prescribe Mirabegron? (Please enter values that total 100%).*

Patients newly diagnosed less than 65yrs of age	%
Patients newly diagnosed more than 65yrs of age	%
Patients Intolerant to Antimuscarinics (AEs like constipation, dry mouth, etc.)	%
Patients with impaired gastric emptying	%
Patients with narrow angle glaucoma	%

Sr. No	Name of Drug	Dose	Frequency	Duration
1	Mirago 25 (Mirabegron 25 mg extended release tablet)
2	Mirago 50 (Mirabegron 50 mg extended release tablet)
3	Any Other
4	Any Other
This field is required.